Scholarlink

Background <p>Waldenström’s macroglobulinemia (WM) is a rare hematologic neoplasm characterized by an indolent clinical course. However, a significant proportion of patients undergo histological transformation to aggressive diffuse large B-cell lymphoma (DLBCL). Long-term population-based data on the transformation and survival are scarce. Based on the Surveillance, Epidemiology, and End Results (SEER) database, we performed this study to estimate the risk of transformation and outcomes of patients with WM.</p> Methods <p>8191 patients with WM were retrieved from the SEER database. Competing risk methods were employed to evaluate the cumulative incidences and putative risk factors for transformation. Survival outcomes were analyzed using Kaplan-Meier and Cox proportional hazards regression.</p> Results <p>The cumulative incidence rates for transformation at 5 and 10 years were 1.0% (95% CI, 0.8%–1.3%) and 1.9% (95% CI, 1.5%–2.2%), respectively. A substantial increase in total mortality was related to the time-dependent transformation (HR, 4.21 [95% CI, 3.36–5.26]; <i>P</i> &lt; 0.001). Patients who presented with transformation &gt; 24 months after WM diagnosis had a longer overall survival (OS) than those who experienced transformation within 24 months (5-year rate, 81.9% [95% CI, 74.7%–89.9%] <i>v</i> 42.7% [95% CI, 26.4%–69.2%]; <i>P</i> &lt; 0.001). The OS was shorter for patients with DLBCL transformed from WM than for those with matched <i>de novo</i> DLBCL (5-year rate, 28.0% [95% CI, 20.5%–38.1%] <i>v</i> 49.5% [95% CI, 41.2%–59.4%]; <i>P</i> = 0.001).</p> Conclusions <p>Histological transformation to DLBCL was associated with significantly increased mortality in patients with WM, and the survival outcomes substantially worse than matched <i>de novo</i> DLBCL cases.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Transformation and survival in patients with Waldenström macroglobulinemia: a population-based study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月21日

查看全文
  • Yu Du,
  • Xiaona Chang,
  • Xiangxiang Li,
  • Shugang Xing

摘要

Background

Waldenström’s macroglobulinemia (WM) is a rare hematologic neoplasm characterized by an indolent clinical course. However, a significant proportion of patients undergo histological transformation to aggressive diffuse large B-cell lymphoma (DLBCL). Long-term population-based data on the transformation and survival are scarce. Based on the Surveillance, Epidemiology, and End Results (SEER) database, we performed this study to estimate the risk of transformation and outcomes of patients with WM.

Methods

8191 patients with WM were retrieved from the SEER database. Competing risk methods were employed to evaluate the cumulative incidences and putative risk factors for transformation. Survival outcomes were analyzed using Kaplan-Meier and Cox proportional hazards regression.

Results

The cumulative incidence rates for transformation at 5 and 10 years were 1.0% (95% CI, 0.8%–1.3%) and 1.9% (95% CI, 1.5%–2.2%), respectively. A substantial increase in total mortality was related to the time-dependent transformation (HR, 4.21 [95% CI, 3.36–5.26]; P < 0.001). Patients who presented with transformation > 24 months after WM diagnosis had a longer overall survival (OS) than those who experienced transformation within 24 months (5-year rate, 81.9% [95% CI, 74.7%–89.9%] v 42.7% [95% CI, 26.4%–69.2%]; P < 0.001). The OS was shorter for patients with DLBCL transformed from WM than for those with matched de novo DLBCL (5-year rate, 28.0% [95% CI, 20.5%–38.1%] v 49.5% [95% CI, 41.2%–59.4%]; P = 0.001).

Conclusions

Histological transformation to DLBCL was associated with significantly increased mortality in patients with WM, and the survival outcomes substantially worse than matched de novo DLBCL cases.